24 May 2013An "import alert", effectively a ban, results in detention without physical examination of drugs from firms that have not met so-called good manufacturing practices
24 May 2013The allegations are designed to divert attention away from Daiichi Sankyo's own failures, said Singh
23 May 2013India's pharmaceutical strategy: IMD's Ralf Boscheck explains why breaking patents may not be the answer
23 May 2013Daiichi Sankyo says unnamed former shareholders of the firm hid information regarding US regulatory probes into Ranbaxy
21 May 2013It’s a free-for-all in the stents business. CGHS has taken a step towards regulation. Will it help?
16 May 2013Prices of 348 medicines, including life saving drugs will be cheaper soon by up to 80 per cent as the new Drug Price Control Order has come into effect
14 May 2013Shares in Ranbaxy Laboratories gain 3%, after declining 4.2% per cent as US fine overhang is seen ending
14 May 2013Shares in Ranbaxy Laboratories Ltd gained 3 per cent, after earlier declining as much as 4.2 per cent
14 May 2013The settlement is its largest-ever with a generic drugmaker over drug safety, according to the US govt
West Asian carriers have flown away with the bulk of seats in recent bilateral deals
Till last week, the tariff value of gold was at $466 per ten grams and silver at $761 per kg.
America's top diplomat John Kerry will embark on his maiden India visit as the Secretary of State to hold 4th Indo-US Strategic Dialogue on June 24
The Cisco CEO on souring relationships, transitions in the market and the huge opportunities that they are spawning
Munshi’s research is fantastic, considering that private television in India is not a very old and matured phenomenon
Quality must be systematic in its approach and systemic to our businesses, says Prashant Hoskote of Max India